Carbamazepine-induced Stevens-Johnson syndrome sparing the skin previously affected by herpes zoster infection in a patient with systemic lupus erythematosus: A reverse isotopic phenomenon

Case Reports in Dermatology

Volumn 2, Issue 2, 2010, Pages 140-145

  Tenea, Daniela ^a  

^a UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

Carbamazepine; Herpes zoster; Reverse isotopic response; Stevens Johnson syndrome; Systemic lupus erythematosus

Indexed keywords

ACICLOVIR; AZATHIOPRINE; CARBAMAZEPINE; PREDNISONE;

ABDOMINAL RADIOGRAPHY; ADULT; ARTICLE; AUTOIMMUNE DISEASE; BURNING SENSATION; CASE REPORT; DRUG INDUCED DISEASE; DRUG METABOLISM; DRUG WITHDRAWAL; FEMALE; HERPES ZOSTER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERCHOLESTEROLEMIA; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; REVERSE ISOTOPIC RESPONSE; STEVENS JOHNSON SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; VIRUS IMMUNITY;

EID: 79951979881     PISSN: None     EISSN: 16626567     Source Type: Journal    
DOI: 10.1159/000319628     Document Type: Article

References (13)

1. Nagasawa K, Yamauchi Y, Tada Y, Kusaba T, Niho Y, Yoshikawa H: High incidence of herpes zoster in patients with systemic lupus erythematosus: an immunological analysis. Ann Rheumatol Diseases 1990;49:630-633. (Pubitemid 20225437)
2. Manzi S, Kuller LH, Kutzer J, Pazin GJ, Sinacore J, Medsger TA Jr, Ramsey-Goldman R: Herpes zoster infection in systemic lupus erythematosus. J Rheumatol 1995;22:1254-1258.
3. Wolf R, Brenner S, Ruocco V, Filioli FG: Isotopic response. Int J Dermatol 1995;34:341-348.
4. Ruocco V, Ruocco E, Ghersetich I, Bianchi B, Lotti T: Isotopic response after herpes virus infection: an update. J Am Acad Dermatol 2002;46:90-94. (Pubitemid 34073483)
5. Mansur TA, Aydingoz IE: Reverse isotopic response: a rarely reported phenomenon. Int J Dermatol 2009;48:783-784.
6. Kang TY, Lee HS, Kim TH, Jun JB, Yoo DH: Clinical and genetic risk factors of herpes zoster in patients with systemic lupus erythematosus. Rheumatol Int 2005;25:97-102.
7. Prelich ZM, Mckenzie RC, Jedrzejowska SA, Norval M: Local immune responses and systemic cytokine responses in zoster: relationship to the development of postherpetic neuralgia. Clin Exp Immunol 2003;131:318-323.
8. Ferrell BP Jr, Mc Leod H: Carbamazepine, HLA-B*1502 and risk of Stevens-Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations. Pharmacogenomics 2008;9:1543-1546.
9. Feliciani C, Verrotti A, Coscione G, Toto P, Morelli F, Di Benedetto A, Salladini C, Chiarellii F, Tulli A: Skin reactions due to anti-epileptic drugs: several case-reports with long-term follow-up. Int J Immunopathol Pharmacol 2003;16:89-93. (Pubitemid 36268146)
10. Chung WH, Hung SI, Hong HS, et al: Medical genetics: a marker for Stevens-Johnson syndrome. Nature 2004;428:486.
11. Mehta TY, Prajapati LM, Mittal B, Joshi CG, Sheth JS, Patel DB, Dave DM, Goyal RK: Association of HLA-B*1502 allele and carbamazepine-induced Stevens-Johnson syndrome among Indians. Indian J Dermatol Venereol Leprol 2009;75:579-582.
12. Caprioni M, Torchia D, Schincaglia E, Volpi W, Frezzolini A, et al: Expression of cytokines and chemokine receptors in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis. British J Dermatol 2006;155:722-728. (Pubitemid 44352552)
13. Mamula MJ: Epitope spreading: the role of self peptides and autoantigen processing by B-lymphocytes. Immunological Reviews 1998;164:231-239.